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Oral tolerance (OT) is characterized as a peripheral immune tolerance form, in which,
mature lymphocytes in lymphoid tissues associated with mucosa, become non-
functional or hypo responsive due to prior oral administration of antigen. OT is an
important immunological phenomenon due to its therapeutic potential in inflammatory
processes and others diseases. Here we evaluated leukotriene role in the induction
of OT, as well as, the production of cytokines IL-5 and IFN-γ in leukotriene deficient
animals (knock-out). Our results suggested that even in the presence of OT and
leukotrienes absence, cytokine IFN-γ remains being secreted, which gives us an
indication of immune system specificity and also that IFN-γ participates in various
immune processes.
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INTRODUCTION
Previous work from other authors brings oral tolerance (OT) not only as a new tool for studying
new therapies for auto-immune processes control but also to reduce chronicity and regulate all
inflammatory responses, especially in the pathophysiology of allergic diseases (Faria and Weiner,
1999; Mayer and Shao, 2004). Mechanisms that regulate the immune response have been proposed
to explain OT, and it is known that leukotrienes are of great importance in modulating all
inflammatory processes, especially those that are characterized by an immune response profile of T
helper type 2 T (Th2). Additionally the triggered response in OT can regulate important cells such
as regulatory CD4+ T cells secreting interleukin-10 (IL-10) or transforming growth factor β (TGF-
β) and it may participate in the control of various cells, such as T cell helper type 1 (Th1) immune
response (Piccirillo et al., 2002; Faria and Weiner, 2006). Further, profile-Th2 cells participate in
mediating specific or non-specific suppression of antigen reactive cells (Miller et al., 1991; Silva
et al., 2010). Thus, in the murine model of OT when we use low doses of antigen the elimination of
regulatory cells in upregulated, whereas higher doses favor clonal expansion in anergy or deletion
processes (Friedman and Weiner, 1994). Therefore, the murine model was chosen to evaluate the
role of leukotrienes in the setting of OT.
Immunological tolerance is described as an active process in which T lymphocytes have a central
function, immunological tolerance is recognized as an important regulation process of immune
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responses (Bluestone, 2011). Therefore, OT is characterized as
a peripheral tolerance form, in which, mature lymphocytes in
lymphoid tissues associated with mucosa become non-functional
or hypo responsive due to the prior oral administration of antigen
(Krause et al., 2000; Weiner et al., 2011).
The induction of local tolerance becomes important since it
guarantees a state of low immune response to certain antigens
administered in an immunogenic form, when they come in
contact with other mucous membranes (Bluestone, 2011; Sgarbi
and Mucida, 2012).
Oral tolerance does not develop, however, in situations where
antigens persist and replicate in the intestinal mucosa, or in
situations of pathogenic viruses and bacteria that invade directly
this environment (Faria and Weiner, 2005).
Antigen administration through oral route for tolerization
base itself on the fact that gastrointestinal tract is in close contact
with a great variety of food, bacterial, parasites and chemical
products, so to overcome this constant antigenic stimulation
a negative regularization on systemic immune responses is
necessary (Olivier, 2004; Gallegos and Bevan, 2006; Ramos
et al., 2008). Such negative regularization on systemic immune
responses becomes necessary, since the differentiation in the
type of response is very important, to prevent responses against
food antigens or edible bacteria, which might lead to food
allergies, mucosa destruction or inflammatory disorders (Raff
and Levitzky, 2012).
However, the induction and maintenance of an OT immune
state are factors highly dependent on the antigen nature and
dose, the frequency and interval of antigen exposition, the time
gap between each antigen exposure, previous immunological
experience, age when the first contact with the antigen occurred
and other genetic factors (Krause et al., 2000; Raff and Levitzky,
2012). Establishment of OT makes use of specific antigen cells
from peripheral lymphoid organs presenting reduction in the
production of interleukins such as IL-2, IL-3, IL-4, IL-5, IL-10,
and IFN-γ in vitro, and further, this response is accompanied by
the inhibition of humoral response. (Chehade and Mayer, 2005).
Leukotrienes are produced by the metabolism of arachidonic
acid (AA) by 5-lipoxygenase path-way, being secreted by various
cells, such as macrophages, neutrophils, eosinophils, and mast
cells (Bousquet et al., 2008). Conversion of AA to leukotrienes
involves the participation of 5-lipoxygenase and FLAP protein
(5-LO–activating protein), which converts AA to leukotrienes in
an unstable form, LTA4 (leukotriene A4) is hydrolysed forming
the LTB4 (leukotriene B4) or conjugated to three amino acids
to form LTC4 (leukotriene C4). These reactions are catalyzed by
LTA4 hydrolase. LTC4 is converted into LTD4 (leukotriene D4),
and LTE4 (leukotriene E4) by extracellular metabolism and these
three molecules are collectively referred as cysteinyl-leukotrienes
(LTs cis) or peptide-leukotrienes (Singh et al., 2010; Nakamura
and Shimizu, 2011). Lymphocytes express leukotrienes receptors,
LTB4 is chemotactic for CD8+ T lymphocytes; cysteinyl-
leukotrienes induce production of chemokine’s RANTES,
(regulated upon activation, normal T cell expressed and
secreted) which is an evidence that chemokine’s might be
involved in OT. The immunosuppression is accompanied by
immunological changes to maintain both peripheral tolerance
and OT thus allowing to maintain immunological competence.
Leukotrienes are potent 5-lipoxygenase-derived inflammatory
mediators and characteristic of leukotriene-related diseases (e.g.,
hypersensitivities, asthma, and allergic rhinitis). Therefore, OT
is a model used to understand the mechanisms and mediators
during immunological anergy, in this study we evaluated the
leukotriene role in the induction of OT, as well as the production
of the cytokines IL-5 and IFN-γ in leukotriene deficient animals.
In this context, the aim of this study was to evaluate the
participation of leukotrienes and modulation of cytokines IL-
5 and IFN-γ during OT in leukotrienes (5-LO-KO) deficient
animals.
MATERIALS AND METHODS
Animals
Young females pathogen free mice belonging to the 129 and
5-LO-KO strains were used (animals deficient in 5-LO) both
weighing between 18–22 g, all kept in the animal house of the
Faculdade de Ciências Farmacêuticas de Ribeirão Preto – USP,
with free access to water and food. This study was approved
and conducted in accordance with the guidelines established
by the University of São Paulo Animal Care Committee, no
02.1.1408.53.8.
Oral Tolerance Induction and
Immunization Protocol
Oral Tolerance was induced by oral gavage using syringe and
metal cannula. It was administered 10 mg of Ova – grade
III (Sigma, St. Louis, MO, USA) diluted in 200 µl of sterile
PBS per animal for 3 consecutive days (groups TOL TOL and
MK +). Control and immune groups received PBS during those
3 days. Seven days after the first dose of oral OVA, mice were
immunized with 100 µg of OVA adsorbed in 1 mg of aluminum
hydroxide and 200 µl of PBS/animal, intraperitoneally. Thirty
days after the beginning of the experiment, a second dose
of aluminum hydroxide and 200 µl of PBS/animal were
administered, intraperitoneally. Control group received only PBS
intraperitoneally during immunization and challenge. Twenty-
eight days after OT induction, the animals were euthanized with
an overdose of anesthetic.
Evaluation of Immune Response
Analysis of Mesenteric Lymph Node Cells
After 30 days of treatment, the lymph nodes were removed and
macerated. Cell suspensions were washed and re-suspended in
complete RPMI-1640 (Sigma; supplemented with 5% of fetal
bovine serum, 40 µg/ml of gentamicin, 20 mM Hepes).
In these tests, preparations of whole cell from organs were
used. Cell suspensions containing 5 × 106 cells in 200 µl
were incubated in the presence or absence of OVA grade III –
Sigma (200 µg/ml) or anti-CD3 (10 µl/ml) in 96 well, flat
bottom (Costar 3595, Coming, NY, USA). Cells were cultured
for 72 h at 37◦C in an oven containing 5% CO2, and 18 h
before the end of the culture, cells were incubated with [3
Frontiers in Microbiology | www.frontiersin.org 2 February 2017 | Volume 8 | Article 242
fmicb-08-00242 February 21, 2017 Time: 16:18 # 3
de Oliveira et al. Leukotrienes in Oral Tolerance
H] thymidine at a concentration of 0.25 µCi/well. Cells were
collected in cells collector (Inotech cell Harvester, USA). Reading
was held in a β-scintillation counter (Beckman, Brea, CA, USA).
Posteriorly, the supernatants were collected and frozen at 20◦C
for subsequent measurement of the cytokines IL-5 and IFN-γ by
ELISA.
Quantification of Cytokines IL-5 and IFN-γ Levels
Serum in Culture Supernatants
ELISA was performed according to the manufacturer instructions
(BD) using purified mAb as capture purified anti-mouse Abs
(lot.5098896 to IL-5 detection; lot. 83480 to IFN-γ, both
from BD Biosciences) to serum cytokines from samples, and
biotinylated anti-mouse mAb (lot. 5098897 to IL-5 detection;
lot.83479 to IFN-γ, both from BD Biosciences) for as cytokines
detection, followed by incubation with streptavidin-peroxidase
(HRP) and substrate TMP (BD Biosciences). The ELISAs
for cytokines detection were performed according to the
manufacturer’s instructions using commercial BD kits (standard
curve) for IL-5 (15.6–1000 pg/ml, assay range) and IFN- _ (9.4–
600 pg/ml). Plates were read in a 96-well spectrophotometer
(Microquant-Sellex, Inc 450 nm) and data was analyzed using
software by comparison against a standard curve generated
using recombinant cytokine at known concentration (Montuschi,
2008).
Statistical Analysis
The results were expressed as mean± SEM. The results obtained
in different experiments were analyzed using both ANOVA and
Mann–Whitney. Statistical analysis was performed using PRISM
(San Diego, CA, USA). The level of significance was 5%.
RESULTS
Analysis of the Total Number of Cells in
the Mesenteric Lymph Nodes of Animals
129 and 5-LO-KO after Induction of Oral
Tolerance (TOL) or Immunization with
OVA
Cell proliferation in the lymph nodes is essential to generate
an immune response. Figure 1A shows the total number of
cells in the mesenteric lymph nodes of animals from line 129,
after induction of TOL and i.p. immunization with OVA. When
compared to the control group, which only received PBS, the
immune animals 129 (OVA/Alumen) and TOL (OVA) showed
an increase in the total cell quantity (Montuschi, 2010).
The data presented demonstrate that the total number of
cells (leukocytes) present in the mesenteric lymph nodes present
significant differences between the different animals studied.
Animals with wild type background (129) exhibit a larger number
of cells in both TOL animals and those previously immunized
with OVA. However, animals presenting background 5-LO-KO
and therefore do not produce leukotrienes have a significantly
lower number in the animals that were immunized with OVA,
when compared to the other TOL groups and even the control
FIGURE 1 | The graph shows the total number of cells in the
mesenteric lymph nodes of animals from the line 129 (A) and 5 LO-KO
(B) after induction of TOL and i.p. immunization, both with OVA. Data
represent mean ± SEM (n = 6 animals). The statistical analysis of the cell
proliferation was performed using the Tukey’s multiple comparison test with
significance set at ∗p < 0.05 when the experimental group was compared to
control group and #p < 0.05 when compared TOL and immune.
animals. We found that animals immunized with OVA/Alumen
(Immune) showed higher numbers in cell proliferation when
compared to TOL animals. Figure 1B shows that the total
cell proliferation in mesenteric lymph nodes is lower in these
immunized animals when compared with the control and TOL
groups (Figure 1B). However, when observing immune deficient
leukotrienes animals, a significant decrease in cell number was
observed.
Analysis of the Modulation of IL-5 in the
Mesenteric Lymph Nodes of Animals 129
and 5-LO-KO
Results in Figure 2A shows that mesenteric lymph node cells
from animals 129 tolerized+anti CD3+anti CD 28 presented
release of IL-5 more significant when compared to the other
stimuli in these lines (Figure 2A). Figure 2B shows the levels
of IL-5 in leukotrienes deficient animals (5-LO-KO). We found
that the TOL group in the presence of antibodies (anti-CD3 and
anti-CD28) induced cytokine production significantly. However,
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FIGURE 2 | Analysis of the concentration of IL-5 in the mesenteric lymph node of animals 129 (A) and 5-LO-KO (B). Data represent mean ± SEM (n = 6
animals). A comparison was made between treatments in culture, that is, between the cytokine basal production and the one stimulated with OVA.
this same group when in contact with OVA and/or anti-CD3 and
anti-CD28 stimuli, increased cytokine production on a discrete
level.
Analysis in the Modulation of IFN-γ in
Mesenteric Lymph Node of Animals 129
and 5-LO-KO
Our results strongly suggested that the presence of anti-CD3 and
anti CD28 stimulation, cells of immune animal 129, presented
an increase in IFN-γ (Figure 3A), whereas, animals TOL on the
same stimulus, showed moderate levels of IFN-γ (Figure 3A).
Data presented in Figure 3B demonstrated a significant increase
in IFN-γ production in animals 5-LO KO on experimental group
TOL when in contact with anti-CD3 and anti-CD28 antibody.
DISCUSSION
Oral tolerance has been classically defined as a decrease in
humoral and/or cellular reactivity after immunization with an
antigen previously administered orally (Weiner et al., 1994;
Smith and Nagler-Anderson, 2005; Round and Mazmanian,
2009). The inflammatory disease of the lungs and Th2-type cells
that it’s released of IL-4 and IL5 play a very important role
in its physio-pathogenesis. Chung et al. (2002) demonstrated
that OT can be induced and maintained in a Th2-related
immune response, and that an ongoing immune response
can be suppressed by the oral administration of antigen
combined with an appropriate feeding regimen. Nevertheless, the
immunological events resulting from the oral administration of
antigen combined with an appropriate feeding regimen are not
fully understood.
We determined the total proliferative capacity of cells in the
mesenteric lymph nodes (which represent one of the different
routes of immune system circulatory migration) in culture and
in the presence or absence of the antigen. Relating the cell
proliferation rate of the control group, which received PBS via
i.p. and water during periods of immunization and challenge,
immune animals 129 (OVA/Alumen) and TOL (OVA) showed
an increase in the number of total cells, as other authors showed
(Macpherson and Smith, 2006).
We also found that animals immunized with OVA/Alumen
(Immune) have higher rates of cell proliferation. Moreover, prior
administration of the antigen orally (TOL) leads to the reduction
in cell production when compared to the cellular immune group
suggesting a slight suppression of cellular immune activity in
these animals (Graph-1-A), according with Worbs et al. (2006).
Animals from the strain 5-LO KO are leukotrienes deficient
because they do not catalyze the enzyme 5-LO. In our results we
found that the total cell proliferation in mesenteric lymph nodes
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FIGURE 3 | Analysis of the concentration of IFN-γ in the mesenteric lymph node of animals 129 (A) and 5-LO-KO (B). Data represent mean ± SEM (n = 6
animals). The non-parametric Mann–Whitney test was used to study cytokine significance set at ∗p < 0.05. A comparison was made between treatments in culture,
that is, between the cytokine basal production and the one stimulated with OVA.
is low in these animals when they are immunized, compared
to control groups and TOL (Graph 1-B). This might give an
indication that the deficiency of leukotrienes, did not prevent
the establishment of tolerance, but when we observed these
animals leukotrienes immune deficient, we observed a significant
decrease in cell number. Fierro et al. (2002) demonstrated a role
in cell proliferation and migration dependent of leukotrienes,
corroborant with our results Fierro et al. (2002). Therefore,
these results suggest that leukotrienes are important mediators
involved in specific immune response, for its absence partially
prevented the immune response (Holgate et al., 2003).
Moreover, our data also corroborates with those described
by Frantz (2004) where animals that have leukotriene synthesis
inhibited by medication also have a low concentration of total
antibodies, which may indicate a tolerance induction. Therefore,
the absences of leukotrienes do not prevent the establishment of
tolerance. Once OT is induced, various events of the reactivity
immune/antigen specific are suppressed, and the production of
immunoglobulin (Ig) classes such as IgE, IgG, IgM and IgA, as
well as production of various cytokines (Weiner et al., 2011).
Concerning the production of IL-5, we found that in animals
129 the release of IL-5 was significant in tolerized animals
+ anti CD3 + anti CD 28 when compared to the other
groups. These isolated results needed to be compared with the
deficient strain of leukotrienes, so we can understand better
from these mediators in OT and its relationship with IL-5. In
other experimental models some authors shown that depending
on the mice strain IL-5 and leukotrienes may participate in
the inflammatory process independently (Anibal et al., 2007).
However, we observed that IL-5 production in animals 5-LO-KO
in the immune group increased significantly, suggesting that IL-
5 in animals immunized with OVA operates in a manner partly
independent of leukotrienes. Therefore, we suggest that IL-5 is
more important than leukotrienes when animals are immunized
than when they are in peripheral tolerance (Graph 2-B). These
data differ from the results obtained in wild animals (129), in
which we observed that IL-5 is more important in tolerance than
in immunization (Graph 2-A). Moreover, Shimizu et al. (2013)
showed that eosinophils, Th2 cytokines, and leukotrienes are
involved in the physiopathology of this asthma model. It is known
that IFN-γ is a cytokine present in several immune responses; we
studied the release of the same in animals’ leukotriene deficient
in the TOL model. Our data strongly suggests that during
tolerance, leukotriene do not participate in the release of IFN-
γ (Graph 3-B), as suggested by Possa et al. (2014), as for the
immune response, when the stimulus was immunization, we
observed the opposite, the absence of leukotrienes prevents the
release of this cytokine (Graph 3-B). These data differ from
the results obtained in wild animals (129), where we observed
that IL-5 is more important in tolerance than in immunization
(Figure 2A).
According to these results we can suggest that leukotrienes
may be important in the regulation of OT once, which are
involved in the modulation of cytokines evaluated in this study.
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The role of leukotrienes in tolerance might be studied in vivo
by measuring these compounds in various biological matrices
including exhaled breath condensate (Montuschi et al., 2014).
So we can conclude that even in the tolerance and in the
leukotrienes absence, the cytokines IFN-γ and IL-5 remains
being secreted, which shows that the immune anergy is specific
and these cytokines participate in various immune processes.
The differences observed before oral treatment with OVA are
strongly correlated with mice response after being fed and further
immunized with antigen.
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